Cargando…

Neoantigens and NK Cells: “Trick or Treat” the Cancers?

Immunotherapy has become an important treatment strategy for cancer patients nowadays. Targeting cancer neoantigens presented by major histocompatibility complex (MHC) molecules, which emerge as a result of non-synonymous somatic mutations with high immunogenicity, is one of the most promising cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Dan, Khawar, Muhammad Babar, Liang, Zhengyan, Gao, Yu, Sun, Haibo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302773/ https://www.ncbi.nlm.nih.gov/pubmed/35874694 http://dx.doi.org/10.3389/fimmu.2022.931862

Ejemplares similares

CAR-NK Cells: From Natural Basis to Design for Kill
por: Khawar, Muhammad Babar, et al.
Publicado: (2021)

Bio-Conjugated Quantum Dots for Cancer Research: Detection and Imaging
por: Liang, Zhengyan, et al.
Publicado: (2021)

From barriers to novel strategies: smarter CAR T therapy hits hard to tumors
por: Khawar, Muhammad Babar, et al.
Publicado: (2023)

The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition
por: Anzar, Irantzu, et al.
Publicado: (2023)

Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer
por: Liang, Hongge, et al.
Publicado: (2022)

Mutation-Derived Neoantigens for Cancer Immunotherapy
por: Castle, John C., et al.
Publicado: (2019)

T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy
por: Sim, Malcolm J. W., et al.
Publicado: (2022)

Determinants for Neoantigen Identification
por: Garcia-Garijo, Andrea, et al.
Publicado: (2019)

Neoantigens in Hematologic Malignancies
por: Biernacki, Melinda A., et al.
Publicado: (2020)

Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
por: Wang, Zhidong, et al.
Publicado: (2020)

Neoantigen: A New Breakthrough in Tumor Immunotherapy
por: Zhang, Zheying, et al.
Publicado: (2021)

The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
por: Karpanen, Terhi, et al.
Publicado: (2017)

Designing neoantigen cancer vaccines, trials, and outcomes
por: Biswas, Nupur, et al.
Publicado: (2023)

Editorial: The Clinical Application of Neoantigens
por: Zhou, Jian-Guo, et al.
Publicado: (2022)

The Neoantigen Landscape of Mycosis Fungoides
por: Sivanand, Arunima, et al.
Publicado: (2020)

Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer
por: Zhang, Xin, et al.
Publicado: (2023)

Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer
por: Zou, Xue-lin, et al.
Publicado: (2021)

Integrative analyses of bulk microarray data to discover genes, pathways, and immune infiltration characteristics associated with targeting of Ewing sarcoma
por: Cao, Binjie, et al.
Publicado: (2023)

Structure Based Prediction of Neoantigen Immunogenicity
por: Riley, Timothy P., et al.
Publicado: (2019)

Structural basis for T cell recognition of cancer neoantigens and implications for predicting neoepitope immunogenicity
por: Mariuzza, Roy A., et al.
Publicado: (2023)

Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal
por: Bianchi, Valentina, et al.
Publicado: (2020)

Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy
por: Efremova, Mirjana, et al.
Publicado: (2017)

Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
por: Wirth, Thomas C., et al.
Publicado: (2017)

NEPdb: A Database of T-Cell Experimentally-Validated Neoantigens and Pan-Cancer Predicted Neoepitopes for Cancer Immunotherapy
por: Xia, Jiaqi, et al.
Publicado: (2021)

Editorial: Autoimmune Diabetes: Molecular Mechanisms and Neoantigens
por: Kent, Sally C., et al.
Publicado: (2022)

Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
por: Guo, Yugang, et al.
Publicado: (2018)

Computational Prediction and Validation of Tumor-Associated Neoantigens
por: Roudko, Vladimir, et al.
Publicado: (2020)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
por: Roerden, Malte, et al.
Publicado: (2019)

Cancer immunotherapy‐targeted glypican‐3 or neoantigens
por: Shimizu, Yasuhiro, et al.
Publicado: (2018)

Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients
por: Bräunlein, Eva, et al.
Publicado: (2017)

Protein citrullination as a source of cancer neoantigens
por: Katayama, Hiroyuki, et al.
Publicado: (2021)

Trick or treat?
por: Cehreli, Murat, et al.
Publicado: (2007)

Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial
por: Rubinsteyn, Alex, et al.
Publicado: (2018)

Improvement of Neoantigen Identification Through Convolution Neural Network
por: Hao, Qing, et al.
Publicado: (2021)

Plasticity of NK cells in Cancer
por: Corvino, Dillon, et al.
Publicado: (2022)

Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy
por: Shou, Jiawei, et al.
Publicado: (2022)

Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond
por: Shin, Eunju, et al.
Publicado: (2023)

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer
por: Aparicio, Belén, et al.
Publicado: (2022)

Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators
por: Qin, Yong, et al.
Publicado: (2017)

Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer
por: Mistretta, Brandon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_645g8s41tgkm9gb73o9478ajmn